IBO vs AAPL: Which Stock is Better?

Side-by-side comparison of Impact Biomedical Inc and Apple Inc in 2026

Comparison Updated:

IBO

Impact Biomedical Inc

$0.66

AAPL

Apple Inc

$263.58

Key Metrics Comparison

MetricIBOAAPLWinner
Market Cap$71.41MN/AIBO
P/E RatioN/A33.68AAPL
EPS (TTM)$N/A$7.91AAPL
Revenue Growth0.0%0.2%AAPL
Gross Margin-1225.0%47.3%AAPL

Analyze IBO

Full quant analysis

Analyze AAPL

Full quant analysis

Analyze Each Stock

Frequently Asked Questions

Is IBO or AAPL a better investment?

Comparing IBO and AAPL: Impact Biomedical Inc has a market cap of $71.41M while Apple Inc has N/A. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.

What is the difference between IBO and AAPL?

IBO (Impact Biomedical Inc) and AAPL (Apple Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.

Which stock has better value: IBO or AAPL?

Based on P/E ratios, compare detailed valuation metrics on our dashboard.

Which is growing faster: IBO or AAPL?

AAPL has higher revenue growth at 0.2% vs 0.0% for IBO.

Which company is more profitable: IBO or AAPL?

Apple Inc (AAPL) has higher gross margins at 47.3% compared to -1225.0% for IBO.

Which is the larger company: IBO or AAPL?

Impact Biomedical Inc (IBO) is larger with a market cap of $71.41M compared to N/A for AAPL.

Should I buy IBO or AAPL in 2026?

Both IBO and AAPL have investment merit. IBO trades at $0.66 while AAPL trades at $263.58. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.

What are the key differences between IBO and AAPL stock?

Key differences: Market Cap ($71.41M vs N/A), P/E Ratio (N/A vs 33.7x), Revenue Growth (0.0% vs 0.2%), Gross Margin (-1225.0% vs 47.3%).

Popular Stock Comparisons